Briacell Therapeutics Corpis A Clinical Stage Immuno Oncology Company Based In West Vancouvercanadafounded In 2014The Company Is Dedicated To Developing Innovative Immunotherapies Aimed At Fighting Cancer And Enhancing Patient Liveswith A Team Of 16 Employeesbriacell Is Led By Ceo William Williams And Focuses On Targeted Cellular Immunotherapiesparticularly For Advanced Breast Cancer The Company S Lead Productbria Imta Cis Currently In A Pivotal Phase 3 Clinical Trial For Advanced Metastatic Breast Cancer And Has Received Fast Track Designation From The Fdabria Imta C Is Designed To Stimulate The Immune System To Attack Tumors And Has Shown Promising Survival Improvements In Patientsespecially Those With Central Nervous System Metastasesadditionallybriacell Is Advancing Its Bria Otsa C And Bria Ots A C Platformswhich Offer Off The Shelf And Personalized Immunotherapies For Various Cancerswith Trials Planned For Prostatelungand Melanoma Cancersthe Company Also Collaborates With Institutions Like The University Of Maryland And The National Cancer Institute To Further Its Research And Development Efforts
United States
